CCAM
MRK icon

Cascades Capital Asset Management’s Merck MRK Stock Holding History

Cascades Capital Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Buy
3,012
+4
+0.1% +$462 0.15% 92
2025
Q4 		$317K Buy
3,008
+5
+0.2% +$469 0.13% 101
2025
Q3 		$252K Buy
3,003
+155
+5% +$12.8K 0.11% 113
2025
Q2 		$225K Buy
2,848
+5
+0.2% +$397 0.12% 102
2025
Q1 		$255K Sell
2,843
-992
-26% -$92.6K 0.14% 100
2024
Q4 		$382K Sell
3,835
-5,287
-58% -$545K 0.2% 73
2024
Q3 		$1.04M Buy
+9,122
New +$1.08M 0.57% 36

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cascades Capital Asset Management's MRK Position: Q1 2026 in Review

Cascades Capital Asset Management increased its Merck (MRK) stake by 0.13% in Q1 2026, buying an estimated $462 and bringing the position to 3,012 shares worth $362K. The position accounts for 0.15% of the portfolio, ranked #92.

Cascades Capital Asset Management first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.04M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cascades Capital Asset Management held 3,012 shares of Merck worth $362K as of Q1 2026.
  • Cascades Capital Asset Management bought 4 Merck shares in Q1 2026, an estimated $462.
  • Merck made up 0.15% of Cascades Capital Asset Management's portfolio in Q1 2026, its #92 holding.
  • Cascades Capital Asset Management first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • Cascades Capital Asset Management's Merck position peaked at $1.04M in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cascades Capital Asset Management's 13F filing for Q1 2026, filed 15 May 2026.